Colorectal Cancer Payment Fairness Act
Sponsored By: Representative Watson Coleman, Bonnie [D-NJ-12]
Introduced
Summary
Eliminates Medicare coinsurance for certain colorectal cancer screening tests and makes that change permanent. This bill would remove the law's time limit and set Medicare coverage at 100 percent for the specified colorectal cancer screening tests in each year after 2026, ending beneficiary coinsurance.
Show full summary
- Seniors and Medicare enrollees: Would owe no coinsurance for the covered colorectal cancer screening tests in each year after 2026, lowering out-of-pocket costs.
- Medicare program: Shifts coverage from 85 percent through 2026 to 100 percent in subsequent years for these tests, increasing Medicare's share of the cost.
Your PRIA Score
Personalized for You
How does this bill affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this bill and every other piece of legislation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Bill Overview
Analyzed Economic Effects
1 provisions identified: 1 benefits, 0 costs, 0 mixed.
No Medicare coinsurance for colon cancer screenings
If enacted, this bill would end coinsurance for certain colorectal cancer screening tests under Medicare. Medicare would pay 100% of the allowed amount for these tests in each year after 2026, so you would not owe the 15% coinsurance. Your savings would equal about 15% of Medicare’s allowed amount per test. The bill also removes the prior end date (January 1, 2030), so this change would not sunset. The policy would take effect upon enactment.
Sponsors & CoSponsors
Sponsor
Watson Coleman, Bonnie [D-NJ-12]
NJ • D
Cosponsors
Rep. Fitzpatrick, Brian K. [R-PA-1]
PA • R
Sponsored 9/30/2025
Rep. Carter, Troy A. [D-LA-2]
LA • D
Sponsored 9/30/2025
Roll Call Votes
No roll call votes available for this bill.
View on Congress.gov